These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 391237)

  • 1. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.
    Winn DM; Wolfe JF; Lindberg DA; Fristoe FH; Kingsland L; Sharp GC
    Arthritis Rheum; 1979 Dec; 22(12):1334-7. PubMed ID: 391237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus and Raynaud's phenomenon.
    Heimovski FE; Simioni JA; Skare TL
    An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility.
    Montecucco C; Caporali R; Cobianchi F; Negri C; Astaldi-Ricotti GC
    Clin Exp Rheumatol; 1992; 10(3):223-7. PubMed ID: 1582066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Raynaud's phenomenon in a patient with antinuclear antibody-negative systemic lupus erythematosus.
    Maxwell CJ; Potter E; Townsend J
    J Natl Med Assoc; 1988 May; 80(5):594-5. PubMed ID: 3262169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters.
    Barada FA; Andrews BS; Davis JS; Taylor RP
    Arthritis Rheum; 1981 Oct; 24(10):1236-44. PubMed ID: 6975630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients.
    Callen JP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of antinuclear antibodies in systemic lupus erythematosus.
    Liu HW; Chi CY; Lin SF; Tsai JH; Chen CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):135-45. PubMed ID: 7026188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence and clinical significance of antibodies to extractable nuclear antigens.
    Hamburger M; Hodes S; Barland P
    Am J Med Sci; 1977; 273(1):21-8. PubMed ID: 300568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis.
    Clotet B; Guardia J; Pigrau C; Lience E; Murcia C; Pujol R; Bacardí R
    Scand J Rheumatol; 1984; 13(1):15-20. PubMed ID: 6609426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome.
    Freundlich B; Makover D; Maul GG
    Ann Intern Med; 1988 Aug; 109(4):295-7. PubMed ID: 3293493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon.
    Shinjo SK; Bonfá E
    Clin Rheumatol; 2011 Feb; 30(2):173-7. PubMed ID: 20349257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
    Caccavo D; Del Porto F; Garzia P; Mitterhofer AP; Galluzzo S; Rigon A; Vadacca M; Navajas MF; Amoroso A; Afeltra A
    Ann Rheum Dis; 2003 Oct; 62(10):1003-5. PubMed ID: 12972482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus.
    Tron F; Bach JF
    Clin Exp Immunol; 1977 Jun; 28(3):426-32. PubMed ID: 302165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Brunner CM; Koffler D
    Arthritis Rheum; 1978 Apr; 21(3):289-94. PubMed ID: 306251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
    Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
    Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANA-negative systemic lupus erythematosus.
    Fessel WJ
    Am J Med; 1978 Jan; 64(1):80-6. PubMed ID: 304670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triad of glomerulonephritis, antinuclear antibodies, and positive skin immunofluorescence. Variant of systemic lupus erythematosus.
    Ascer K; Walker JA; Lief PD; Barland P; Bank N
    Am J Med; 1983 Jan; 74(1):83-9. PubMed ID: 6336892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus.
    Beaufils M; Kouki F; Mignon F; Camus JP; Morel-Maroger L; Richet G
    Am J Med; 1983 Feb; 74(2):201-5. PubMed ID: 6600581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.